Axogen, Inc. — Director's Dealing 2020

Jun 12, 2020

SEC Form 4/A — Form 4/A

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2020-06-01

Reporting Person: NEELS GUIDO J (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-01	Stock Option (right to purchase)	$9.72	A	12605	Acquired	2030-06-01	Common Stock (12605)	Direct
2020-06-01	Restricted Stock Units	$	A	6173	Acquired		Common Stock (6173)	Direct

Footnotes

F1: Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $120,000 valuation as of the grant date and vests on June 2, 2021, one year from the anniversary of the grant date. One-half of the annual equity grant value is in the form of non-qualified stock options and one-half of the annual equity grant value is in the form of restricted stock units.

F2: Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock.

F3: The original Form 4, filed June 3, 2020, incorrectly stated the number of derivative securities (Column 5), the number of shares (Column 7) and number of derivatives securities beneficially owned following reported transaction (Column 9) for both the Stock Options and Restricted Stock Units. Footnote 1 has also been amended to reflect the accurate number of stock options and restricted stock units.